{"id":"W3159788506","doi":"10.3899/jrheum.201532","title":"Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis","year":2021,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"LEO Pharma; Incyte; Janssen Scientific Affairs; Gilead Sciences; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Adverse effect; Internal medicine; Placebo; Discontinuation; Secukinumab; Arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02693238,0.002372074,0.006599428,0.001533453,0.0005176251,0.002410092,0.0008126728,0.00160047,0.0025757],"category_scores_gemma":[0.0265815,0.00117273,0.01375633,0.00212287,0.000508486,0.001399953,0.001378643,0.002010579,0.0005087568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001024096,"about_ca_system_score_gemma":0.001409214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008878972,"about_ca_topic_score_gemma":0.001767491,"domain_scores_codex":[0.9845341,0.009035605,0.002280916,0.001537542,0.002112924,0.0004988369],"domain_scores_gemma":[0.9801558,0.006728338,0.008597079,0.001918816,0.001969632,0.0006302032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5865208,0.0008000908,0.05535895,0.007614136,0.2597187,0.0001831515,0.0002101654,0.00331806,0.006844463,0.0001458074,0.00405953,0.07522617],"study_design_scores_gemma":[0.1718064,0.08575331,0.3736264,0.0008553808,0.3509094,0.0007881009,0.0001647555,0.002476269,0.004453401,0.0006216817,0.008325811,0.0002191008],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7375231,0.230196,0.007089255,0.001087743,0.0008258109,0.002598998,0.0149483,0.0005046538,0.005226003],"genre_scores_gemma":[0.9709249,0.01609269,0.001293828,0.00071043,0.0005824951,0.001261869,0.008093462,0.00007481732,0.0009656072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02693238,"threshold_uncertainty_score":0.1424338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01910106613689069,"score_gpt":0.2940377414660967,"score_spread":0.274936675329206,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}